CANBERRA, March 12 (CNA) - Australia said on Friday (Mar 12) it will continue to roll out AstraZeneca's COVID-19 vaccine as there was no evidence of a link to blood clots, despite some European countries suspending its use.

Denmark, Norway and Iceland on Thursday suspended the use of AstraZeneca's COVID-19 vaccine following reports of the formation of blood clots in some people who had been vaccinated.

Australia's government said that while its pharmaceutical regulator was monitoring those cases, there would be no pause in the roll-out of the vaccine.

"We're getting on with the vaccine, we're getting on with the roll-out," Deputy Prime Minister Michael McCormack told reporters in Melbourne.

Australia's Chief Medical Officer Paul Kelly said there is no evidence to suggest the vaccine caused blood clots.

"We do take them seriously and investigate," Kelly said in an emailed statement, referring to the reports of blood clots.

CANBERRA: Australia said on Friday (Mar 12) it will continue to roll out AstraZeneca's COVID-19 vaccine as there was no evidence of a link to blood clots, despite some European countries suspending its use.

Denmark, Norway and Iceland on Thursday suspended the use of AstraZeneca's COVID-19 vaccine following reports of the formation of blood clots in some people who had been vaccinated.

Australia's government said that while its pharmaceutical regulator was monitoring those cases, there would be no pause in the roll-out of the vaccine.

"We're getting on with the vaccine, we're getting on with the roll-out," Deputy Prime Minister Michael McCormack told reporters in Melbourne.

Australia's Chief Medical Officer Paul Kelly said there is no evidence to suggest the vaccine caused blood clots.

"We do take them seriously and investigate," Kelly said in an emailed statement, referring to the reports of blood clots.